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Abstract
Background: Clinical and experimental data suggest that the inflammatory response is impaired in diabetics and
can be modulated by insulin. The present study was undertaken to investigate the role of insulin on the early
phase of allergic airway inflammation.
Methods: Diabetic male Wistar rats (alloxan, 42 mg/Kg, i.v., 10 days) and controls were sensitized by s.c. injection of
ovalbumin (OA) in aluminium hydroxide 14 days before OA (1 mg/0.4 mL) or saline intratracheal challenge. The
following analyses were performed 6 hours thereafter: a) quantification of interleukin (IL)-1b, tumor necrosis factor
(TNF)-a and cytokine-induced neutrophil chemoattractant (CINC)-1 in the bronchoalveolar lavage fluid (BALF) by
Enzyme-Linked Immunosorbent Assay, b) expression of E- and P- selectins on lung vessels by immunohistochemistry,
and c) inflammatory cell infiltration into the airways and lung parenchyma. NPH insulin (4 IU, s.c.) was given i.v. 2
hours before antigen challenge.
Results: Diabetic rats exhibited significant reduction in the BALF concentrations of IL-1b (30%) and TNF-a (45%),
and in the lung expression of P-selectin (30%) compared to non-diabetic animals. This was accompanied by
reduced number of neutrophils into the airways and around bronchi and blood vessels. There were no differences
in the CINC-1 levels in BALF, and E-selectin expression. Treatment of diabetic rats with NPH insulin, 2 hours before
antigen challenge, restored the reduced levels of IL-1b, TNF-a and P-selectin, and neutrophil migration.
Conclusion: Data presented suggest that insulin modulates the production/release of TNF-a and IL-1b, the
expression of P- and E-selectin, and the associated neutrophil migration into the lungs during the early phase of
the allergic inflammatory reaction.
Background
Hormones and other endocrine factors play a modulat-
ing role in allergic inflammation, with the effects of glu-
cocorticoids or adrenergic agents being obvious
examples. It has been already demonstrated that
alloxan-induced diabetic rats present markedly reduced
inflammatory reactions to allergen challenge in the air-
ways [1,2] and in the pleural space [3] unrelated to
changes in the number of total blood leukocytes or
blood glucose levels [1], but ascribed to a reduction in
mast cell degranulation upon antigen challenge [3-5].
Treatment of diabetic rats with insulin restores the
number of degranulated mast cells, levels of histamine
release, and airway reactivity to ovalbumin [5]. Because
of that, we decided to further investigate the early phase
of allergic airway inflammation, which steps of the cell
migration process are impaired in diabetic rats, and at
what level is insulin acting to restore it.
It has long been recognized that the inflammatory
response in diabetic patients is impaired [6-12].
Abnormalities of neutrophil function have been shown
to occur during inflammation in alloxan-induced dia-
betic rats [6,7]. These include: decreased leukocyte-
endothelial cell interactions [10,13] and reduced number
of leukocytes in inflammatory lesions [10,14-16];
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tor (TNF)-a release [17]; reduced lymph node retention
capacity [18]; a decrease in the generation of prostaglan-
din (PG)-E2 [19]; reduced production/release and tran-
scription of pro-inflammatory (interleukin (IL)-1b,
TNF-a), and anti-inflammatory (IL-10) cytokines, and
reduced expression of intercellular adhesion molecule
(ICAM)-1 [7,8]. Alloxan, currently used to induce dia-
betes in experimental animals, acts through selective
uptake by low affinity GLUT2 glucose transporter into
the beta-cell leading to the destruction of the transpor-
ter protein by oxygen free radicals [20,21]. It was
demonstrated that, in addition to the significant reduc-
tion in body weight gain and hyperglycemia, polydipsia,
polyuria, glycosuria, presence of ketone bodies, hypoin-
sulinemia, and elevated levels of glycosylated haemoglo-
bin are present in Wistar rats after alloxan injection
[7-16]. The aim of the present study was to compare
alloxan-induced diabetic rats with non-diabetics for the
levels of TNF-a, IL-1b, and cytokine-induced neutrophil
chemoattractant (CINC)-1, in the bronchoalveolar
lavage fuid (BALF), and the expression of E and P selec-
tins in lung tissue during the early phase of the allergic
lung inflammation. Furthermore, we evaluated the effect
of insulin treatment of diabetic rats on these parameters.
Data presented show that insulin restored the deficient
neutrophil migration observed in diabetic rats in
response to allergen challenge. This occurred in parallel
with increased TNF-a and IL-1b levels in BALF, and
increased expression of E- and P- selectins.
Methods
Animals
Male Wistar rats weighing 200 ± 20 g (about 2 months of
age) at the beginning of the experiments were used. The
animals were maintained at 23 ± 2°C under a cycle of 12
hours light: 12 hours darkness and were allowed access
to food and water ad libitum. All experiments were in
accord with ethical principles in animal research adopted
by the Brazilian College of Animal Experimentation.
Approval of the Animal Subject Committee of the Heart
Institute (InCor), University of São Paulo Medical School,
was obtained prior to initiating the experiments.
Induction of diabetes mellitus and insulin treatment
Diabetes mellitus was induced by an intravenous injec-
tion of 42 mg/kg of alloxan monohydrate (Sigma Che-
mical Co., St. Louis, MO, USA) dissolved in physiologic
saline (0.9% NaCl) [7-9,17-21]. Control rats were
injected with physiologic saline only. Ten days thereafter
blood glucose concentrations were determined and ani-
mals that presented glucose above 200 mg/dL were
used. Blood samples were obtained from the cut tip of
the rat tail and glucose determined with the aid of a
blood glucose monitor (Eli Lilly, São Paulo, SP, Brazil).
A group of diabetic rats received 4 IU s.c. of neutral
protamine Hagedorn (NPH) insulin (Eli Lilly, São Paulo,
SP, Brazil) 2 hours before ovalbumin (OA, grade III;
Sigma Chemical Co.) challenge. Because the maximum
serum concentration (Cmax) of NPH insulin is reached
between 6 and 8 h after subcutaneous administration,
we decided to give insulin to the animal 2 h before OA
challenge, as in previous studies in this line of insulin
treatment [7-9]. The dose of insulin injection was cho-
sen based on previous studies from our group [7-9]
because the dose was able to restore inflammatory para-
meters that are suppressed in diabetic rats. Although
this dose was not sufficient to return glucose levels in
animals with diabetes to normal values, the serum insu-
lin was above normal levels during the time of the
experiment (6 h after OA challenge) [7-9,17-19].
Sensitization to ovalbumin and antigen challenge
The animals were actively immunized with ovalbumin
(OA) by subcutaneous injection of 0.2 mL sterile physio-
logic saline containing 0.1 mg OA and 8 mg Al(OH)3
[1]. The animals were anesthetized 14 days thereafter
with an intraperitoneal injection (150 mg/Kg) of S (+)-
ketamine hydrochloride (Ketamin-S(+), Cristalia, Itapira,
SP, Brazil) and the trachea was exposed through a mid-
line ventral incision of approximately 0.5 cm length in
the neck. Physiologic saline solution (0.9% NaCl; 0.4 mL)
containing 1 mg OA was instilled into the airways. The
incision was closed with sutures and the animals
returned to their cages.
Bronchoalveolar lavage fluid
BALF was performed 6 hours after the intratracheal
administration of OA or saline. The animals were
anesthetized, as described above, and the abdominal
cavity was opened for blood exsanguination from the
abdominal aorta. The lungs were then lavaged by instil-
lation of 10 mL of phosphate buffered saline (PBS), at
room temperature, through a polyethylene tube (1 mm
in diameter) inserted into the trachea. The first 10 mL
instilled into the lungs were withdrawn and reinstilled
twice. After centrifugation (500 g for 15 min), the super-
natant was frozen at -70°C for cytokine measurements.
The lungs were further lavaged with 15 mL PBS
(3 times 5 mL) to harvest leukocytes. The BALF was
n o tu s e di ft h er e t r i e v e dv o l u m ew a sl e s st h a n8 5 %o f
the 25 mL instilled. Total cell counts were determined
by using an automatic hemacytometer (CELM, São
Paulo, SP, Brazil). Differential cell counts were carried
out on hematoxylin-eosin stained slides under oil
immersion microscopy. A total of 100 cells were
counted and classified as neutrophils, eosinophils or
mononuclear cells based on morphologic criteria.
Martins et al. BMC Pulmonary Medicine 2010, 10:39
http://www.biomedcentral.com/1471-2466/10/39
Page 2 of 9Lung morphometric analysis
For the analysis of cell infiltration around blood vessels
and bronchi animals were anesthetized, the chest wall
was opened and the lungs removed. A portion of the
left inferior lobe close to the hilum and a portion of the
apex were removed, fixed in 4% paraformaldehyde solu-
tion in sodium phosphate buffer, 0.2 M, pH 7.2, for
24 h, and then dehydrated in ethanol. Samples were
embedded in paraplast embedding media (Sigma Chemi-
cal Co., St. Louis, MO), seccioned at 5 μm, and stained
with hematoxylin and eosin (Merk, Darmstadt, Ger-
many). Morphometric analysis of perivascular and peri-
bronchiolar infiltration of mononuclear cells,
neutrophils and eosinophils were performed in the lung
sections. Determinations were made in 3 randomly
selected fields close to the vessel (4 vessels/sample) and
in the surrounding airway tissue (4 bronchi/sample), by
employing a 10
4 μm
2 total area reticle. Data were then
averaged for each animal.
Quantification of cytokines in the BALF
The concentrations of IL-1b,T N F - a and CINC-1 in the
BALF supernatant were determined by enzyme-linked
immunosorbent assay (ELISA) using commercially avail-
able kits according to the manufacturer’si n s t r u c t i o n s
(R & D Systems Inc., Minneapolis, MN, USA). The sen-
sitivity of the assays was 15 pg/mL.
Immunohystochemistry for E- and P- selectin
Six hours after OA or saline intratracheal challenge, the
animals were anesthetized and exsanguinated as
described above. After tracheostomy, 10 mL of tissue
freezing medium (Leica Instruments Gmbh, Nussloch,
Germany) diluted in PBS (1:1, v/v) were instilled into
the airways. The lungs were harvested through a median
sternotomy, immersed in hexan and frozen into liquid
nitrogen. Serial 8 μmc r y o s t a ts e c t i o n sw e r ea d h e r e dt o
glass slides previously coated with organo-sylane (Sigma
Chemical Co., St. Louis, MO, USA). For the immunode-
tection of both E- and P- selectins on lung microvessels,
a biotin conjugated anti-rat E-selectin (CD62E) polyclo-
n a la n t i b o d y( R&DS y s t e m sI n c . ,M i n n e a p o l i s ,M N ,
USA) or anti-human P-selectin (CD62P) monoclonal
antibody (Immunotech, Marseille, France) were used.
After fixation in acetone, tissue samples were incubated
with the antibody overnight at 4°C, rinsed in PBS and
treated with streptoavidin-fluorescein (Amersham Phar-
macia Biotech, London, UK) for 1 hour at room tem-
perature. After washing the slides with PBS, samples
were treated with Vectashield mounting medium con-
taining propidium iodide (Vector, CA, USA) in order to
preserve the fluorescence. Negative control samples
were incubated with PBS instead of the primary anti-
body. The system used for image acquisition include the
Coosnap Pro Color digital camera (Nikon, Tokyo,
Japan), coupled to a triocular fluorescent microscope
(Nikon), and Software Image-Pro® Plus, version 4.1
(Media Cybernetics, Silver Spring, MD, USA). Results
are presented as mean fluorescence intensity.
Statistical analysis
Data are presented as means ± SEM and analyzed by
ANOVA followed by the Tukey-Kramer multiple com-
parisons test. p > 0.05 was considered significant.
Results
Body weight gain and blood glucose levels
Table 1 shows that, relative to controls, animals ren-
dered diabetic by injection of alloxan exhibited a signifi-
cant reduction in body weight gain during the
experimental period, and sharply elevated blood glucose
levels. Treatment of diabetic animals with a single dose
of NPH insulin induced a significant reduction in blood
glucose levels but it was not sufficient to reduce glyce-
mia to control values.
Role of insulin on leukocyte migration
Relative to control (non-diabetic) OA-challenged rats,
leukocyte counts in the BALF of diabetic rats were
reduced after OA challenge due to a 90% reduction in
the number of neutrophils, and 50% reduction in the
number of mononuclear cells. Treatment of diabetic
animals with a single dose of NPH insulin, 2 hours
before OA challenge, restored the impaired cell migra-
tion observed in diabetic rats to values attained in con-
trol non-diabetis rats. Only few eosinophils were found
and there were no differences among groups (Table 2).
The morphometric analysis of lung parenchyma showed
that in both, diabetic and non diabetic rats, the allergic
reaction induced cell infiltration around blood vessels
and bronchi 6 h after challenge. However, diabetic rats
exhibited a 40% reduction in the number of neutrophils,
and a 25% reduction in the number of mononuclear
cells in both perivascular and peribronchiolar sites.
Treatment of diabetic rats with 4 IU NPH insulin before
Table 1 General characteristics of the animals
Groups Body weight gain (g) Blood glucose (mg/dL)
Control 147 ± 12 87 ± 2
Diabetic 11 ± 11* 531 ± 26*
Diabetic + insulin 13 ± 12 * 257 ± 15 *
†
Rats were rendered diabetic by the injection of alloxan (42 mg/Kg, i.v.), and
measurement of body weight was carried out 24 days afterwards. Rats were
immunized with OA and blood glucose levels in the 3 groups were
determined 6 hours after antigen challenge. Insulin (NPH, 4 IU/rat, s.c.) was
administered 2 hours before the intratracheal instillation procedure.Values are
means ± SEM. The number of animals in each group was 9. *P < 0.001
comparing diabetic with control (non-diabetic) rats.
†P < 0.001 comparing
insulin-treated vs non-treated diabetic rats.
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found in control non-diabetic rats. The number of eosi-
nophils was very low and did not differ among groups
(Table 2).
Role of insulin on cytokines levels
In the BALF of non-diabetic rats a 3.5-fold increase in
the concentration of IL-1b and a 4.3-fold increase in
the concentration of TNF-a were observed after instilla-
tion of OA into immunized rats compared to saline
instilled rats. In contrast, a reduction in the levels of IL-
1b (38%) and TNF-a (54%) were observed in OA-
instilled diabetic rats compared to OA-instilled non-dia-
betic rats. Results are illustrated in Figure 1. Levels of
these cytokines were similar in saline-instilled diabetic
and non-diabetic rats. Treatment of diabetic rats with a
single dose of NPH insulin, 2 hours before OA chal-
lenge completely restored BALF IL-1b and TNF-a levels
(Figure 1). A 3-fold increase in the BALF concentrations
of CINC-1 was observed after exposure of non-diabetic
rats to OA compared to saline-instilled rats. Similar
results were observed in diabetic rats after OA challenge
compared to saline-instilled diabetic rats (Figure 1).
Levels of CINC-1 were similar in saline-instilled diabetic
and non-diabetic animals. Furthermore, CINC-1 levels
did not change in diabetic rats after treatment with a
single dose of NPH insulin, 2 hours before OA chal-
lenge (Figure 1).
Table 2 Effect of insulin on the inflammatory cells
infiltration into the airways and lung parenchyma
Control
(non-diabetic)
Diabetic Diabetic
+insulin
BALF (Cells × 10
6)
Mononuclears 14.28 ± 0.58 7.11 ± 0.18* 13.08 ± 0.74
†
Neutrophils 9.63 ± 0.43 0.94 ± 0.11* 9.51 ± 0.58
†
Eosinophils 0.04 ± 0.02 0.02 ± 0.01 0.03 ± 0.01
Perivascular (Cells/10
4 μm
2)
Mononuclears 74.54 ± 2.65 56.75 ± 1.72* 66.18 ± 2.15
†
Neutrophils 26.97 ± 1.56 15.58 ± 1.46* 33.13 ± 3.75
†
Eosinophils 0.40 ± 0.16 0.50 ± 0.15 0.35 ± 0.13
Peribronchiolar (Cells/10
4 μm
2)
Mononuclears 75.38 ± 2.90 56.30 ± 1.79* 67.50 ± 3.10
†
Neutrophils 27.63 ± 2.44 18.08 ± 1.79* 32.12 ± 3.23
†
Eosinophils 0.46 ± 0.24 0.25 ± 0.11 0.35 ± 0.17
Rats were rendered diabetic by the injection of alloxan (42 mg/Kg, i.v.) 10 days
before sensitization. In both non-diabetic and diabetic rats, active sensitization
against ovalbumin (OA) was performed 14 days before OA intratracheal
instillation. Insulin (NPH, 4 IU/rat, s.c.) was administered 2 hours before OA
challenge. Bronchoalveolar lavage fluid (BALF) was performed 6 hours
thereafter (9 animals in each group). Morphometric analysis was made in the
stained slides of lung tissue. Determinations were made in 3 randomly selected
fields for the presence of cells in the perivascular (4 vessels/sample) and
peribronchiolar (4 bronchi/sample) tissue (3 animals in each group). Values are
means ± SEM. *P < 0.001 comparing diabetic with control (non-diabetic) rats.
†P < 0.001 comparing insulin-treated vs non-treated diabetic rats.
Figure 1 IL-1b,T N F - a and CINC-1 concentrations in the
bronchoalveolar lavage fluid of ovalbumin (OA) sensitized
non-diabetic and diabetic rats 6 hours after OA (experimental)
or saline (control) intratracheal instillation. Insulin (NPH, 4 IU/rat
s.c.) was given to diabetic rats 2 hours before OA challenge. Values
are means ± SEM for 5 to 7 animals in each group. *P < 0.001
comparing OA challenged with the control in the corresponding
group (diabetic or non-diabetic).
†P < 0.0001 comparing diabetic
rats treated vs non-treated with insulin.
‡P < 0.001 comparing OA
challenged with the diabetic or non-diabetic group.
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E-selectin expression, as evidenced by immune staining,
increased 1.5-fold in lung microvessels of sensitized non-
diabetic rats 6 hours after OA challenge compared to sal-
ine-instilled rats. Similar results were observed in
OA-challenged diabetic rats compared to saline-instilled
diabetic rats. Despite no significant differences between
non-diabetic and diabetic animals, expression of E-selec-
tin was increased (77%) after insulin treatment of diabetic
rats. Quantitative evaluation of the immune staining is
illustrated in Figure 2. Representative sections of these
preparations are shown in Figure 3. Levels of E-selectin
were not significantly different between saline-instilled
diabetic and non-diabetic rats. Expression of P-selectin
on lung microvessels of non-diabetics increased 1.8-fold
after exposure to OA compared to saline-instilled rats. In
contrast, in diabetic rats the increase in P-selectin in
response to allergic stimulation was only 1.3-fold. Treat-
ment of diabetic rats with a single dose of NPH insulin,
2 hours before OA challenge completely restored P-selec-
tin expression Quantitative evaluation of the immune
staining is illustrated in Figure 2. Representative sections
of these preparations are shown in Figure 4.
Discussion
Results presented here suggest that insulin modulates
the development of the inflammatory reaction to aller-
gen challenge by its ability to regulate the production of
IL-1b and TNF-a and the expression of P-selectin. This
is supported by the following observations: (a) relative
to control non-diabetic rats, alloxan-induced diabetic
rats exhibited reduced levels of IL-1b and TNF-a in the
BALF and reduced lung P-selectin expression; (b) this
was accompanied by a significant reduction in the num-
ber of neutrophils and mononuclear leukocytes har-
vested from the BALF and infiltrating perivascular and
peribronchiolar tissues; (c) a complete recovery of the
impaired responses was observed under the influence of
insulin; (d) despite no significant difference in lung
E-selectin expression between diabetic and non-diabetic
rats, an increase in the expression of this adhesion
molecule was observed after insulin treatment.
In a previously published study, Vianna and Garcia-
Leme have demonstrated that insulin modulates leuko-
cyte migration into the airways during the course of the
allergic reaction [1]. In agreement with their findings,
we found that the number of neutrophils and mononuc-
lear cells in the BALF of diabetic rats was markedly
reduced in response to OA challenge. In addition,
reduced numbers of neutrophils and mononuclear leu-
kocytes were observed surrounding blood vessels and
bronchi of diabetic rats. The impaired response was
apparently not related to antibody production or to
blood glucose levels [1] but ascribed to a reduction in
mast cell degranulation upon antigen challenge [5].
Indeed, it has been reported that mast cells from dia-
betic rats were shown to be refractory to antigen stimu-
lation both in vivo [3] and in vitro [4].
Reversal of the impaired responses was attained by
treatment of diabetic rats with insulin. Despite an
Figure 2 Quantitative evaluation of the immune staining for
E- and P- selectins on lung microvessels of ovalbumin (OA)
sensitized non-diabetic and diabetic rats 6 hours after OA
(experimental) or saline (control) instillation. Insulin (NPH, 4 IU/
rat s.c.) was given to diabetic rats 2 hours before OA challenge.
Values are means ± SEM for 8 samples/rat, 3 animals/group.
Analyses were performed by using the software image-pro Plus,
version 4.1, Media Cybernetics. *P < 0.001 comparing OA challenged
with the control in the corresponding group (diabetic or non-
diabetic).
†P < 0.0001 comparing diabetic rats treated vs non-treated
with insulin.
‡P < 0.001 comparing OA challenged with the diabetic
or non-diabetic group.
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after treatment with a single dose of insulin, diabetic
rats are still hyperglycemic compared to controls. Insu-
lin in adequate concentrations seems to be required for
the normal function of alveolar macrophages [22,23],
endothelial cells and neutrophils during the course of
the inflammatory process [6]. Moreover, levels of
serum corticosterone did not differ significantly
between diabetic rats and controls [7]. Accordingly,
the suggestion is that the restorative effect observed in
insulin-treated rats might be primarily linked to a con-
tinuing insulin deficiency rather than to the hypergly-
caemic state of diabetic animals, or to a prevalence of
glucocorticoids.
On activation, mast cells rapidly synthesize bioactive
metabolites of arachidonic acid, prostaglandins and leu-
kotrienes, and many mediators are released by triggered
exocytosis from intracellular stores, including histamine,
Figure 3 E-selectin lung tissue microphotographs. The immune staining for E-selectin on lung microvessels of ovalbumin (OA) sensitized
non-diabetic and diabetic rats 6 hours after OA (experimental) or saline (control) instillation. Insulin (NPH, 4 IU/rat s.c.) was given to diabetic rats
2 hours before OA challenge. Values are means ± SEM for 8 samples/rat, 3 animals/group. Analyses were performed by using the software
image-pro Plus, version 4.1, Media Cybernetics. The microphotographs of lung tissue were obtained from control non-diabetic rats non-sensitized
and instilled with saline (CNSSAL) or sensitized and instilled with saline (CSENSAL) or sensitized and instilled with OA (CSENOA), diabetic rats
non-sensitized instilled with saline (DNSSAL) or sensitized and instilled with OA (DSENOA), and insulin treated diabetic rats sensitized instilled
with OA (DSENOA+I). *Indicates the vessel lumen. Lung sections (8 μm) were stained for the detection of E-selectin (original magnification ×
1500). *P < 0.001 comparing OA challenged with the control in the corresponding group (diabetic or non-diabetic).
†P < 0.0001 comparing
diabetic rats treated vs non-treated with insulin.
‡P < 0.001 comparing OA challenged with the diabetic or non-diabetic group.
Martins et al. BMC Pulmonary Medicine 2010, 10:39
http://www.biomedcentral.com/1471-2466/10/39
Page 6 of 9numerous proteases, and TNF-a [3-5,24]. Gene expres-
sion is also activated, leading to de novo synthesis of sev-
eral cytokines and chemokines [24]. Results presented
herein showed that in diabetic rats the levels of IL-1b
and TNF-a in the BALF were significantly lower than in
non-diabetic rats under allergic stimulation. Treatment
with insulin completely restored the release of IL-1b and
TNF-a during the allergic lung inflammation. Indeed,
insulin treatment of diabetic rats increases the levels of
these cytokines [7] associated with increased expression
of their transcripts in the lungs [8] during the course of
lipopolysaccharide (LPS)-induced lung inflammation.
Cytokines such as IL-1b and TNF-a amplify the inflam-
matory response by stimulating the release of chemoat-
tractant factors by alveolar macrophages and airways
epithelial cells, and the expression of adhesion molecules
Figure 4 P-selectin lung tissue microphotographs. The immune staining for P-selectin on lung microvessels of ovalbumin (OA) sensitized
non-diabetic and diabetic rats 6 hours after OA (experimental) or saline (control) instillation. Insulin (NPH, 4 IU/rat s.c.) was given to diabetic rats
2 hours before OA challenge. Values are means ± SEM for 8 samples/rat, 3 animals/group. Analyses were performed by using the software
image-pro Plus, version 4.1, Media Cybernetics. The microphotographs of lung tissue were obtained from control non-diabetic rats non-sensitized
and instilled with saline (CNSSAL) or sensitized and instilled with saline (CSENSAL) or sensitized and instilled with OA (CSENOA), diabetic rats
non-sensitized instilled with saline (DNSSAL) or sensitized and instilled with OA (DSENOA), and insulin treated diabetic rats sensitized instilled
with OA (DSENOA+I). *Indicates the vessel lumen. Lung sections (8 μm) were stained for the detection of P-selectin (original magnification ×
1500). *P < 0.001 comparing OA challenged with the control in the corresponding group (diabetic or non-diabetic).
†P < 0.0001 comparing
diabetic rats treated vs non-treated with insulin.
‡P < 0.001 comparing OA challenged with the diabetic or non-diabetic group.
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asthma in general, TNF-a mediates recruitment of neu-
trophils and eosinophils during airway inflammation [26].
CINC-1, a member of IL-8 family of chemokines that sti-
mulate neutrophil migration into the lungs, is known to
be induced by IL-1b and TNF-a [27]. Despite the signifi-
cantly lower concentrations of IL-1b and TNF-a in the
BALF of OA challenged diabetic rats, as demonstrated in
the present study, equivalent increases in the levels of
CINC-1 were observed in diabetic and control rats.
Furthermore, CINC-1 levels did not change after treat-
ment of diabetic rats with insulin, which suggest that the
production/release of CINC-1 might be independent of
insulin. However, it is possible that 6 hours was not the
time required for CINC-1 to reach the maximum release
after OA challenge. Other chemokines, such as macro-
phage inflammatory protein (MIP)-1a,o rM I P - 2
(renamed CINC-3) could be responsible for the recruit-
ment of neutrophils into the lung rather than CINC-1.
Chemokines produced locally then promote the arrest
of leukocytes on the endothelium and their migration
into surrounding tissues [26,27]. Thus, the migration of
leukocytes into an asthmatic lung is dependent upon
multiple mechanisms that are initiated by binding of
leukocytes at the endothelial border to selectins [26-29].
Increased expression of E- and P-selectins has been
observed in asthmatic patients [28,29], suggesting that
these molecules are up-regulated in human disease and
may contribute to the development of both bronchial
inflammation and airway hyperreactivity. It has been
shown that P-selectin deficient mice exhibit a reduction
of airway hyperresponsiveness, and decreased cellular
recruitment into the airways in response to OA inhala-
tion [30]. Data, presented herein, showed that lung neu-
trophils infiltration occurred in parallel with the
increased endothelial expression of E- and P-selectins in
lung microvessels of OA-challenged rats. Unexpectedly,
only a reduction in the expression of P-selectin after
OA challenge was associated with reduced cellular
migration that was completely restored by treatment of
diabetic rats with insulin. Nevertheless, despite no sig-
nificant differences between diabetic and control groups
after OA-challenge, E-selectin expression on lung vessels
further increased after insulin treatment of diabetic rats.
These results suggest that insulin modulates E- and P-
selectin in the allergic airway inflammation. Further-
more, it has been shown that insulin modulates the
expression of ICAM-1 on the alveolar epithelium and
the associated leukocyte infiltration during the course of
allergen-induced airway inflammation in rats [31].
Indeed, insulin treatment of diabetic rats up-regulates
ICAM-1 protein and gene expression in the lungs dur-
ing the course of LPS-induced lung inflammation [7,8].
Regulation of ICAM-1 transcript by insulin involves, at
least in part, activation of the nuclear factor (NF)-B
pathway in the lungs of diabetic rats [8], suggesting a
mechanism through which insulin might modulate E-
and P-selectin expression in the early phase of the aller-
gic lung inflammation.
The ability of insulin to mediate expression of inflam-
matory cytokines as well as of adhesion molecules sug-
gests a role for insulin in the regulation of inflammation.
Further studies on the mechanisms of insulin action on
leukocytes and endothelial cells are needed to understand
its role in allergic lung inflammation.
Clinical asthma appears to be less severe when dia-
betes mellitus is superimposed. Data from epidemiologi-
cal studies in children with type-1 diabetes mellitus
[32,33] are consistent with data from previously pub-
lished studies [34,35], reporting an inverse relationship
between atopy and diabetes mellitus. It is possible to
speculate that asthma is suppressed in diabetic indivi-
duals because there is a relative lack of insulin which, in
turn, would allow asthma to manifest itself clinically. In
this context, it has been already demonstrated that insu-
lin modulates the early response to antigen provocation
by controlling mast cell degranulation [5]. Data pre-
sented herein suggest that insulin modulates levels of
cytokines, expression of adhesion molecules, and cell
migration during the early phase of allergic airway
inflammation. This effect of insulin should be primarily
due to the elevated levels of insulin maintained during
the experiment since blood glucose levels were only par-
tially reduced by this protocol of insulin treatment.
Conclusion
Data presented suggest that insulin modulates the pro-
duction/release of the pro-inflammatory cytokines, TNF-
a and IL-1b, the expression of P- and E-selectin, and
the associated neutrophil migration into the lungs dur-
ing the early phase of the allergic inflammatory reaction.
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